Genome-wide DNA methylation analysis and epigenetic variations associated with Congenital Aortic Valve Stenosis (AVS)

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Radhakrishna, Uppala ^a   Albayrak, Samet ^b   Alpay Savasan, Zeynep ^a   Zeb, Amna ^a   Turkoglu, Onur ^a   Sobolewski, Paul ^a   Bahado Singh, Ray O ^a  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AORTA VALVE STENOSIS; APOA5 GENE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CPG ISLAND; DIAGNOSTIC ACCURACY; DNA METHYLATION; ENDOCYTOSIS; EPIGENETICS; GENE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIATION; HUMAN; NEWBORN; PATHOGENESIS; PCSK9 GENE; PREDICTION; PROTEIN BINDING; AORTIC VALVE STENOSIS; CASE CONTROL STUDY; FEMALE; GENETIC EPIGENESIS; GENETICS; MALE; VALIDATION STUDY;

AORTIC VALVE STENOSIS; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; MALE;

EID: 84968911245     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154010     Document Type: Article

References (51)

1. Khoshnood B, Lelong N, Houyel L, Thieulin AC, Jouannic JM, Magnier S, et al. Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study. Heart. 2012; 98(22):1667-73. doi: 10.1136/heartjnl-2012-302543 PMID: 22888161.
2. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. The Journal of pediatrics. 2008; 153(6):807-13. doi: 10.1016/j.jpeds.2008.05.059 PMID: 18657826; PubMed Central PMCID: PMC2613036.
3. Loffredo CA. Epidemiology of cardiovascular malformations: prevalence and risk factors. American journal of medical genetics. 2000; 97(4):319-25. PMID: 11376444.
4. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005; 111(7):920-5. doi: 10.1161/01.CIR.0000155623.48408.C5 PMID: 15710758.
5. Pierpont ME, Basson CT, Benson DW Jr., Gelb BD, Giglia TM, Goldmuntz E, et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007; 115(23):3015-38. doi: 10.1161/CIRCULATIONAHA.106.183056 PMID: 17519398.
6. Sheffield VC, Pierpont ME, Nishimura D, Beck JS, Burns TL, Berg MA, et al. Identification of a complex congenital heart defect susceptibility locus by using DNA pooling and shared segment analysis. Human molecular genetics. 1997; 6(1):117-21. PMID: 9002679.
7. McGregor TL, Misri A, Bartlett J, Orabona G, Friedman RD, Sexton D, et al. Consanguinity mapping of congenital heart disease in a South Indian population. PloS one. 2010; 5(4):e10286. doi: 10.1371/journal.pone.0010286 PMID: 20422016; PubMed Central PMCID: PMC2858208.
8. Monteleone PL, Fagan LF. Possible X-linked congenital heart disease. Circulation. 1969; 39(5):611-4. PMID: 5787314.
9. Hoffman JI, Kaplan S. The incidence of congenital heart disease. Journal of the American College of Cardiology. 2002; 39(12):1890-900. PMID: 12084585.
10. Patel SS, Burns TL. Nongenetic risk factors and congenital heart defects. Pediatric cardiology. 2013; 34(7):1535-55. doi: 10.1007/s00246-013-0775-4 PMID: 23963188.
11. Probst V, Le Scouarnec S, Legendre A, Jousseaume V, Jaafar P, Nguyen JM, et al. Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation. 2006; 113(6):856-60. doi: 10.1161/CIRCULATIONAHA.105.569467 PMID: 16461814.
12. Le Gal G, Bertault V, Bezon E, Cornily JC, Barra JA, Blanc JJ. Heterogeneous geographic distribution of patients with aortic valve stenosis: arguments for new aetiological hypothesis. Heart. 2005; 91(2):247-9. doi: 10.1136/hrt.2004.037093 PMID: 15657257; PubMed Central PMCID: PMC1768671.
13. Friedman WF. Aortic stenosis. In Adama FH, Emmnoulides GC (Eds) Heart diseases in infants, children and adolescents including the fetus and young adults 5th edition Baltimore MD Williams & Wilkins 1995.
14. McBride KL, Marengo L, Canfield M, Langlois P, Fixler D, Belmont JW. Epidemiology of noncomplex left ventricular outflow tract obstruction malformations (aortic valve stenosis, coarctation of the aorta, hypoplastic left heart syndrome) in Texas, 1999-2001. Birth defects research Part A, Clinical and molecular teratology. 2005; 73(8):555-61. doi: 10.1002/bdra.20169 PMID: 16007587; PubMed Central PMCID: PMC1361303.
15. Csaky-Szunyogh M, Vereczkey A, Kosa Z, Gerencser B, Czeizel AE. Risk factors in the origin of congenital left-ventricular outflow-tract obstruction defects of the heart: a population-based case-control study. Pediatric cardiology. 2014; 35(1):108-20. doi: 10.1007/s00246-013-0749-6 PMID: 23843102.
16. Abuhamad A, Chaoui RC. A practical guide to fetal echocardiography. Normal and abnormal hearts. Second edition 2010: LippincottWilliams and Wilkins Philadelphia, PA. 2010.
17. Kehler L, Biro O, Lazar L, Rigo J Jr., Nagy B. Elevated hsa-miR-99a levels in maternal plasma may indicate congenital heart defects. Biomed Rep. 2015; 3(6):869-73. doi: 10.3892/br.2015.510 PMID: 26623032; PubMed Central PMCID: PMC4660590.
18. Czeizel AE, Dobo M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth defects research Part A, Clinical and molecular teratology. 2004; 70(11):853-61. doi: 10.1002/bdra.20086 PMID: 15523663.
19. Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G. Homocysteine lowering interventions for preventing cardiovascular events. The Cochrane database of systematic reviews. 2009;(4:):CD006612. doi: 10.1002/14651858.CD006612.pub2 PMID: 19821378.
20. Bahado-Singh RO, Zaffra R, Albayarak S, Chelliah A, Bolinjkar R, Turkoglu O, et al. Epigenetic markers for newborn congenital heart defect (CHD). J Matern Fetal Neonatal Med. 2015:1-7.
21. Ailes EC, Gilboa SM, Riehle-Colarusso T, Johnson CY, Hobbs CA, Correa A, et al. Prenatal diagnosis of nonsyndromic congenital heart defects. Prenatal diagnosis. 2014; 34(3):214-22. doi: 10.1002/pd.4282 PMID: 24222433.
22. Knowles R, Griebsch I, Dezateux C, Brown J, Bull C, Wren C. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. Health technology assessment. 2005; 9(44):1-152, iii-iv. PMID: 16297355.
23. Joo JE, Wong EM, Baglietto L, Jung CH, Tsimiklis H, Park DJ, et al. The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array. BMC Biotechnol. 2013; 13:23. doi: 10.1186/1472-6750-13-23 PMID: 23497093; PubMed Central PMCID: PMC3610215.
24. Wong N, Morley R, Saffery R, Craig J. Archived Guthrie blood spots as a novel source for quantitative DNA methylation analysis. Biotechniques. 2008; 45(4):423-4, 6, 8 passim. doi: 10.2144/000112945 PMID: 18855769.
25. Docherty LE, Rezwan FI, Poole RL, Jagoe H, Lake H, Lockett GA, et al. Genome-wide DNA methylation analysis of patients with imprinting disorders identifies differentially methylated regions associated with novel candidate imprinted genes. Journal of medical genetics. 2014; 51(4):229-38. doi: 10.1136/jmedgenet-2013-102116 PMID: 24501229; PubMed Central PMCID: PMC3963529.
26. Pan H, Chen L, Dogra S, Teh AL, Tan JH, Lim YI, et al. Measuring the methylome in clinical samples: improved processing of the Infinium Human Methylation450 BeadChip Array. Epigenetics: official journal of the DNA Methylation Society. 2012; 7(10):1173-87. doi: 10.4161/epi.22102 PMID: 22964528; PubMed Central PMCID: PMC3469459.
27. Liu Y, Aryee MJ, Padyukov L, Fallin MD, Hesselberg E, Runarsson A, et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol. 2013; 31(2):142-7. doi: 10.1038/nbt.2487 PMID: 23334450; PubMed Central PMCID: PMCPMC3598632.
28. Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics. 2013; 8(2):203-9. doi: 10.4161/epi.23470 PMID: 23314698; PubMed Central PMCID: PMCPMC3592906.
29. Wilhelm-Benartzi CS, Koestler DC, Karagas MR, Flanagan JM, Christensen BC, Kelsey KT, et al. Review of processing and analysis methods for DNA methylation array data. Br J Cancer. 2013; 109(6):1394-402. doi: 10.1038/bjc.2013.496 PMID: 23982603; PubMed Central PMCID: PMC3777004.
30. Daca-Roszak P, Pfeifer A, Zebracka-Gala J, Rusinek D, Szybinska A, Jarzab B, et al. Impact of SNPs on methylation readouts by Illumina Infinium HumanMethylation450 BeadChip Array: implications for comparative population studies. BMC Genomics. 2015; 16(1):1003. doi: 10.1186/s12864-015-2202-0 PMID: 26607064; PubMed Central PMCID: PMC4659175.
31. Gu. Z. ComplexHeatmap: Making Complex Heatmaps. R package version 1.6.0. https://githubcom/jokergoo/ComplexHeatmap.2015.
32. Altorok N, Tsou PS, Coit P, Khanna D, Sawalha AH. Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies. Annals of the rheumatic diseases. 2014. doi: 10.1136/annrheumdis-2014-205303 PMID: 24812288.
33. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. J R Statist Soc B. 1995; 57:289-300.
34. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols. 2009; 4(1):44-57. doi: 10.1038/nprot.2008.211 PMID: 19131956.
35. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research. 2009; 37(1):1-13. doi: 10.1093/nar/gkn923 PMID: 19033363; PubMed Central PMCID: PMC2615629.
36. Sheng W, Qian Y, Zhang P, Wu Y, Wang H, Ma X, et al. Association of promoter methylation statuses of congenital heart defect candidate genes with Tetralogy of Fallot. Journal of translational medicine. 2014; 12:31. doi: 10.1186/1479-5876-12-31 PMID: 24479926; PubMed Central PMCID: PMC3915623.
37. Hutter CM, Austin MA, Humphries SE. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview. Am J Epidemiol. 2004; 160(5):430-5. doi: 10.1093/aje/kwh238 PMID: 15321839.
38. Austin MA, Hutter CM, Zimmern RL, Humphries SE. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol. 2004; 160(5):421-9. doi: 10.1093/aje/kwh237 PMID: 15321838.
39. Rabus MB, Kayalar N, Sareyyupoglu B, Erkin A, Kirali K, Yakut C. Hypercholesterolemia association with aortic stenosis of various etiologies. J Card Surg. 2009; 24(2):146-50. doi: 10.1111/j.1540-8191.2009.00814.x PMID: 19267822.
40. Chui MC, Newby DE, Panarelli M, Bloomfield P, Boon NA. Association between calcific aortic stenosis and hypercholesterolemia: is there a need for a randomized controlled trial of cholesterol-lowering therapy? Clin Cardiol. 2001; 24(1):52-5. PMID: 11195607.
41. Li Y. Functional analysis of Dusp27, a novel target gene of the JAK1/STAT1 pathway, in myogenesis. Thesis (PhD) - Hong Kong University of Science and Technology,. 2011.
42. Arrington CB, Bleyl SB, Matsunami N, Bonnell GD, Otterud BE, Nielsen DC, et al. Exome analysis of a family with pleiotropic congenital heart disease. Circ Cardiovasc Genet. 2012; 5(2):175-82. doi: 10.1161/CIRCGENETICS.111.961797 PMID: 22337856; PubMed Central PMCID: PMC3329568.
43. Arsenault BJ, Dube MP, Brodeur MR, de Oliveira Moraes AB, Lavoie V, Kernaleguen AE, et al. Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans. Arterioscler Thromb Vasc Biol. 2014; 34(2):457-62. doi: 10.1161/ATVBAHA.113.302730 PMID: 24334872.
44. Liu HK, Wang CT, Zhang SZ, Xiao CY, Li XF, Zhang KL, et al. [Association of APOA5 gene single nucleotide polymorphism with levels of lipids and coronary heart disease in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004; 21(4):335-8. PMID: 15300628.
45. Wang J, Ban MR, Kennedy BA, Anand S, Yusuf S, Huff MW, et al. APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia. Nat Clin Pract Cardiovasc Med. 2008; 5(11):730-7. doi: 10.1038/ncpcardio1326 PMID: 18779834.
46. Cohen JC, Boerwinkle E, Mosley TH Jr., Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006; 354(12):1264-72. doi: 10.1056/ NEJMoa054013 PMID: 16554528.
47. Click ES, Cox B, Olson SB, Grompe M, Akkari Y, Moreau LA, et al. Fanconi anemia-like presentation in an infant with constitutional deletion of 21q including the RUNX1 gene. Am J Med Genet A. 2011; 155A(7):1673-9. doi: 10.1002/ajmg.a.34024 PMID: 21626672.
48. Lindstrand A, Malmgren H, Sahlen S, Schoumans J, Nordgren A, Ergander U, et al. Detailed molecular and clinical characterization of three patients with 21q deletions. Clin Genet. 2010; 77(2):145-54. doi: 10.1111/j.1399-0004.2009.01289.x PMID: 19863549.
49. Conrad M, Jakupoglu C, Moreno SG, Lippl S, Banjac A, Schneider M, et al. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol. 2004; 24(21):9414-23. doi: 10.1128/MCB.24.21.9414-9423.2004 PMID: 15485910; PubMed Central PMCID: PMC522221.
50. Lindsay EA. Chromosomal microdeletions: dissecting del22q11 syndrome. Nat Rev Genet. 2001; 2(11):858-68. doi: 10.1038/35098574 PMID: 11715041.
51. Helmer RA, Martinez-Zaguilan R, Dertien JS, Fulford C, Foreman O, Peiris V, et al. Helicase-like transcription factor (Hltf) regulates G2/M transition, Wt1/Gata4/Hif-1a cardiac transcription networks, and collagen biogenesis. PLoS One. 2013; 8(11):e80461. doi: 10.1371/journal.pone.0080461 PMID: 24278285; PubMed Central PMCID: PMC3835564.